Papillary Thyroid Cancer

• Papillary thyroid cancer is the most prevalent form of thyroid cancer, often growing slowly.
• It typically presents as a painless lump in the neck, though other symptoms can occur.
• Diagnosis involves physical examination, imaging, and fine-needle aspiration biopsy.
• Treatment commonly includes surgery, sometimes followed by radioactive iodine therapy.
• The prognosis for papillary thyroid cancer is generally excellent, especially with early detection.

What is Papillary Thyroid Cancer?

What is papillary thyroid cancer refers to a malignancy that develops in the follicular cells of the thyroid gland, a butterfly-shaped organ located at the base of the neck. It accounts for approximately 80% of all thyroid cancer cases, making it the most common type. This cancer typically grows slowly and often spreads to lymph nodes in the neck, though distant spread is less common.

According to the American Cancer Society, thyroid cancer incidence rates have been stable or slightly decreasing in recent years after rising for several decades, with papillary thyroid cancer remaining the predominant subtype. While the exact cause is often unknown, risk factors include exposure to radiation, a family history of thyroid cancer, and certain genetic syndromes. It is more common in women than men and can occur at any age, though it is most frequently diagnosed in individuals between 30 and 50 years old.

Recognizing Symptoms and Diagnosis

Recognizing the signs of thyroid cancer is vital for timely intervention. The most common of the Papillary thyroid cancer symptoms is the presence of a painless lump or nodule in the neck, which may be felt during a self-exam or discovered incidentally during a routine physical examination. Other potential symptoms, though less frequent, can include:

• Difficulty swallowing or breathing
• Hoarseness or other voice changes that persist
• Swollen lymph nodes in the neck
• Pain in the neck or throat

Diagnosis typically begins with a physical examination where a doctor checks the neck for lumps. If a nodule is found, further investigation is warranted. This often involves imaging tests such as an ultrasound of the neck, which can help determine the size, location, and characteristics of the nodule. The definitive diagnosis of papillary thyroid cancer is usually made through a fine-needle aspiration (FNA) biopsy, where a small sample of cells is taken from the nodule and examined under a microscope by a pathologist. Blood tests to check thyroid hormone levels are also common, though thyroid function is often normal in patients with papillary thyroid cancer.

Treatment Options and Outlook

Once diagnosed, Papillary thyroid cancer treatment options are highly effective and tailored to the individual patient, considering factors like tumor size, stage, and whether it has spread. The primary treatment is almost always surgery to remove the cancerous thyroid tissue. This may involve a lobectomy (removal of part of the thyroid) or a total thyroidectomy (removal of the entire thyroid gland). In some cases, lymph nodes in the neck may also be removed if cancer has spread to them.

Following surgery, some patients may receive radioactive iodine (RAI) therapy. This treatment targets and destroys any remaining thyroid tissue or cancer cells that were not removed during surgery, particularly if the cancer is larger or has spread. Thyroid hormone replacement therapy with levothyroxine is also essential after a total thyroidectomy to replace the hormones the thyroid gland would normally produce and to help suppress the growth of any remaining cancer cells. The Papillary thyroid cancer prognosis is generally excellent, with very high survival rates, especially when detected early. For localized papillary thyroid cancer, the 5-year survival rate is over 99%, according to the National Cancer Institute’s SEER program. Even for regional disease (spread to nearby lymph nodes), the prognosis remains very favorable. Regular follow-up with blood tests and imaging is crucial to monitor for recurrence.